Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Goyang-si
Clinical trial register · South Korea

Clinical Trials in Goyang-si, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Goyang-si 23 Seoul 10 Goyang 5 Busan 3 Suwon 2
Narrow the registerReset
Recruitment status
Phase
Site location
Goyang-si23 Seoul10 Goyang5 Busan3 Suwon2
All 16 locations
Target enrolment
to

Trials with a site in Goyang-si

23 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
By invitation
Patients With High-grade Pancreatic Neuroendocrine Tumors
NCT07121478Neuroendocrine Tumor of Pancreas, Pancreatic Neuroendocrine Tumors
National Cancer Center, Korea
Phase 2
46
Goyang-si
2025-09-23
Recruiting
National Cancer Center, Korea
Phase 2
80
Goyang-si
2025-09-10
Not yet open
National Cancer Center, Korea
Not applicable
54
Goyang-si
2025-08-22
Recruiting
National Cancer Center, Korea
Phase 2
82
Goyang-si
2024-11-19
Recruiting
National Cancer Center, Korea
Not applicable
50
Goyang-si
2024-11-04
Recruiting
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
NCT06168292Biliary Tract Carcinoma, Radiotherapy, Radio-frequency Ablation
National Cancer Center, Korea
Not applicable
53
Goyang-si
2024-04-01
By invitation
Active Surveillance for Low-risk Papillary Thyroid Carcinoma
NCT06261190Thyroid Cancer, Papillary Thyroid Carcinoma
National Cancer Center, Korea
Observational
499
Goyang-si, Seongnam, Seoul
2024-03-06
Recruiting
Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
NCT06135896Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma
National Cancer Center, Korea
Phase 2
98
Goyang-si
2024-01-16
Recruiting
National Cancer Center, Korea
Not applicable
120
Goyang-si, Seoul
2023-12-27
Recruiting
National Cancer Center, Korea
Phase 2
120
Suwon, Goyang-si, Seoul
2023-09-05
Recruiting
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748Breast Cancer, Locally Recurrent Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Reoperation
National Cancer Center, Korea
Phase 2
30
Goyang-si
2023-08-13
Recruiting
National Cancer Center, Korea
Not applicable
128
Goyang-si
2023-07-06
Recruiting
National Cancer Center, Korea
Phase 3
520
Sejong, Goyang-si, Suwon, Pusan, Seoul
2023-05-31
Recruiting
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
NCT05982691CNS Germinoma, CNS Tumor, Asian Consortium
National Cancer Center, Korea
Observational
400
Goyang-si
2022-08-05
Active, closed
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
NCT05316181Epithelial Ovarian Cancer, Platinum Resistant, Recurrent Ovarian, HIPEC
National Cancer Center, Korea
Phase 3
140
Goyang-si, Seoul
2022-04-07
By invitation
National Cancer Center, Korea
Observational
128
Goyang-si
2021-11-15
Active, closed
National Cancer Center, Korea
Phase 2
30
Goyang-si
2021-11-15
Recruiting
Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type
NCT04890171Stomach Cancer, Undifferentiated Type, Expanded Indication of Endoscopic Resection
National Cancer Center, Korea
Not applicable
708
Goyang-si
2021-06-11
By invitation
National Cancer Center, Korea
Observational
5,000
Goyang-si
2019-07-03
By invitation
National Cancer Center, Korea
Observational
500
Goyang-si
2018-09-21
By invitation
National Cancer Center, Korea
Observational
120
Goyang-si
2018-09-21
Active, closed
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
NCT01678027Gastric Cancer, Helicobacter Pylori Infection, Family Members
National Cancer Center, Korea
Phase 3
1,838
Goyang-si
2004-11
Active, closed
Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD
NCT02407119Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection
National Cancer Center, Korea
Phase 3
470
Goyang-si
2003-06
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/goyang-si

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Goyang-si that also match the filters currently applied.

How many clinical trials are recruiting in Goyang-si?

12 of the 23 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Goyang-si), 23 studies
PhaseStudiesRecruitingShare
Phase 27530.4%
Not applicable6526.1%
Observational6126.1%
Phase 34117.4%

Most active sponsors

Lead sponsors with the most studies (Goyang-si)
Lead sponsorStudiesRecruiting
National Cancer Center, Korea2312
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.